Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialysis Patients
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
To study whether peroxisome proliferator-activated receptor-gamma activation in peritoneal
dialysis patients will reduce inflammation, atherosclerosis, calcification and improve
survival of peritoneal dialysis patients